Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Bucknelly21on Jan 04, 2022 11:39am
115 Views
Post# 34281829

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Possible chinese partner?

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Possible chinese partner?I guess what I'm saying is it's more than a share price to me, we are always waiting and always giving excuse for a company that quite frankly has no business being public. A week ago it's tax loss selling, next week it's scarlets posting a link on Nash and the correlation to obesity, then it will be well 1a looks promising but we have to wait for 1b to be completed. It's never ending with these guys. I don't care how we got there with Nash point is we are there and nothing. Up until the ph3 approval we were all saying that was the missing piece. Well that came and gone and they didn't get a red cent of value to any of us. You think if pfizer had a Nash protocol ready they could find a partner? I bet they could easily because they have the right people in place. I probably need to just take a break for a while Thtx. I believe in the science just not the people trying to capitalize on it... 
<< Previous
Bullboard Posts
Next >>